- Home
- LITE vs IKT Comparison
LITE vs IKT Comparison
Compare LITE & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LITE
- IKT
- Stock Information
- Founded
- LITE 2015
- IKT 2008
- Country
- LITE United States
- IKT United States
- Employees
- LITE N/A
- IKT N/A
- Industry
- LITE Telecommunications Equipment
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- LITE Telecommunications
- IKT Health Care
- Exchange
- LITE Nasdaq
- IKT Nasdaq
- Market Cap
- LITE 8.4B
- IKT 140.5M
- IPO Year
- LITE N/A
- IKT 2020
- Fundamental
- Price
- LITE $172.35
- IKT $1.59
- Analyst Decision
- LITE Buy
- IKT Buy
- Analyst Count
- LITE 14
- IKT 2
- Target Price
- LITE $131.15
- IKT $8.00
- AVG Volume (30 Days)
- LITE 3.9M
- IKT 92.1K
- Earning Date
- LITE 11-06-2025
- IKT 11-13-2025
- Dividend Yield
- LITE N/A
- IKT N/A
- EPS Growth
- LITE N/A
- IKT N/A
- EPS
- LITE 0.37
- IKT N/A
- Revenue
- LITE $1,645,000,000.00
- IKT N/A
- Revenue This Year
- LITE $42.13
- IKT N/A
- Revenue Next Year
- LITE $19.63
- IKT N/A
- P/E Ratio
- LITE $447.30
- IKT N/A
- Revenue Growth
- LITE 21.03
- IKT N/A
- 52 Week Low
- LITE $45.65
- IKT $1.12
- 52 Week High
- LITE $171.87
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- LITE 78.23
- IKT 43.91
- Support Level
- LITE $160.85
- IKT $1.50
- Resistance Level
- LITE $171.87
- IKT $1.63
- Average True Range (ATR)
- LITE 6.58
- IKT 0.09
- MACD
- LITE 1.77
- IKT -0.01
- Stochastic Oscillator
- LITE 98.77
- IKT 23.73
About LITE Lumentum Holdings Inc.
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.